Skip to main content
. 1998 Jul 25;317(7153):252–254. doi: 10.1136/bmj.317.7153.252

Table 1.

Mortality of patients with Parkinson’s disease by drug use

Treatment group Person-time of observation (years) No of deaths Mortality ratio (95% CI)
Adjusted for age and sex Full adjustment*
Levodopa alone 9028.0 1124 1.00 1.00
Selegiline alone 1118.3 136 1.13 (0.95 to 1.35) 1.14 (0.95 to 1.36)
Selegiline with levodopa 4102.0 460 1.12 (1.00 to 1.25) 1.10 (0.98 to 1.23)
Selegiline alone or with levodopa 5220.3 596 1.12 (1.01 to 1.24) 1.11 (1.00 to 1.23)
*

Adjusted for age, sex, calendar year, smoking habit, regional health authority, diagnosis group, use of antidepressants (and specifically tricyclics and serotonin reuptake inhibitors), history of cerebrovascular disease, history of ischaemic heart disease, and incident or prevalent disease at entry to study.